PSMA4 Protein
Introduction
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">PSMA4 Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>PSMA4</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>PSMA4</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=PSMA4" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">2 edges</a></td>
</tr>
</table>
Psma4 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
PSMA4 is one of the seven alpha-ring subunits of the 20S proteasome core and is required for assembly and stable function of proteasome particles. In [neurons](/entities/neurons), PSMA4 supports proteostasis by enabling ubiquitin-dependent degradation through the 26S proteasome complex. Because neurons are long-lived and highly sensitive to proteotoxic stress, reduced proteasome capacity can accelerate disease-linked protein accumulation in [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), and related disorders.[@mckinnon2014][@ebrahimifakhari2017][@zhang2019]
Protein Context
...PSMA4 Protein
Introduction
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">PSMA4 Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>PSMA4</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>PSMA4</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=PSMA4" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">2 edges</a></td>
</tr>
</table>
Psma4 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
PSMA4 is one of the seven alpha-ring subunits of the 20S proteasome core and is required for assembly and stable function of proteasome particles. In [neurons](/entities/neurons), PSMA4 supports proteostasis by enabling ubiquitin-dependent degradation through the 26S proteasome complex. Because neurons are long-lived and highly sensitive to proteotoxic stress, reduced proteasome capacity can accelerate disease-linked protein accumulation in [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), and related disorders.[@mckinnon2014][@ebrahimifakhari2017][@zhang2019]
Protein Context
- Protein name: Proteasome subunit alpha type-4
- Gene: [PSMA4](/genes/psma4)
- UniProt: [P25789](https://www.uniprot.org/uniprotkb/P25789/entry)
- Major complex: [26S Proteasome](/proteins/26s-proteasome)
- Pathway: [Ubiquitin-Proteasome System Dysfunction in Neurodegeneration](/mechanisms/ubiquitin-proteasome-dysfunction)
PSMA4 is a structural (non-catalytic) alpha subunit. Its primary role is to help form the outer alpha ring of the 20S core particle and maintain gate architecture that controls substrate entry into proteolytic chambers.[@murata2009][@gu2018][@kopp1997]
Structure And Assembly Biology
Alpha-ring position and gate function
The 20S core consists of two outer alpha rings and two inner beta rings. Alpha subunits, including PSMA4, regulate substrate access and coordinate with regulatory particles that convert 20S cores into fully functional 26S proteasomes.[@murata2009][@kopp1997]
Proteasome biogenesis proceeds through ordered alpha/beta assembly states that require dedicated chaperones and quality-control checkpoints. Experimental work in mammalian systems demonstrates specific alpha-ring intermediates involving alpha4-containing complexes, directly relevant to PSMA4 maturation biology.[@gu2018][@kopp1997]
Functional consequences for neurons
If assembly efficiency falls, cells accumulate damaged proteins, activate stress pathways, and increasingly depend on compensatory [autophagy](/entities/autophagy). In neurons, this compensation is often incomplete under chronic disease stress.[@mckinnon2014][@korolchuk2020]
Disease-Relevant Mechanisms
Alzheimer's disease
AD studies report early [UPS](/mechanisms/ubiquitin-proteasome-system) decline and broad proteostasis failure, with proteasome downregulation detectable before advanced tissue loss. This supports a model where PSMA4-containing proteasomes are functionally stressed in prodromal and symptomatic stages.[@zhang2019][@fricker2025]
Parkinson's disease and alpha-synuclein stress
Alpha-synuclein can impair proteasome activity and create feed-forward proteotoxic loops. In dopaminergic neurons, early UPS impairment is observed in alpha-synuclein-linked settings, consistent with proteasome dysfunction as a pathogenic amplifier.[@ebrahimifakhari2017][@mazzetti2020]
Cross-disease proteostasis vulnerability
Across neurodegenerative disorders, UPS failure is a recurring convergence mechanism. PSMA4 should therefore be interpreted as a structural dependency of proteasome integrity rather than a high-frequency monogenic driver.[@mckinnon2014][@korolchuk2020]
Experimental And Translational Notes
Experimental approaches
Assembly-state profiling: quantify 20S/26S composition and alpha-ring intermediates under stress or gene perturbation.[@gu2018][@kopp1997]
Cellular activity assays: measure chymotrypsin-like proteasome function in neuronal or iPSC-derived models with proteotoxic challenge.[@ebrahimifakhari2017][@zhang2019]
Integrated proteostasis studies: combine UPS readouts with autophagy metrics to map compensation limits.[@mckinnon2014][@korolchuk2020]Therapeutic implications
- Proteostasis rescue: interventions that preserve proteasome function may delay toxic aggregate accumulation.
- Upstream burden reduction: lowering aggregate-forming proteins (for example [Alpha-Synuclein](/proteins/alpha-synuclein)) can indirectly protect UPS throughput.[@ebrahimifakhari2017][@mazzetti2020]
- Systems biomarkers: pairing proteasome-related signatures with inflammatory and synaptic biomarkers may improve disease staging.[@fricker2025]
See Also
- [PSMA4](/genes/psma4)
- [26S Proteasome](/proteins/26s-proteasome)
- [Ubiquitin-Proteasome System in Neurons](/cell-types/ubiquitin-proteasome-system)
- [Ubiquitin-Proteasome System Dysfunction in Neurodegeneration](/mechanisms/ubiquitin-proteasome-dysfunction)
- [Alpha-Synuclein](/proteins/alpha-synuclein)
Background
The study of Psma4 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
- [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
- [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
References
[McKinnon C, Tabrizi SJ, Failure of ubiquitin proteasome system: risk for neurodegenerative diseases (2014)](https://pubmed.ncbi.nlm.nih.gov/25413678/)
[Ebrahimi-Fakhari D, McLean PJ, Unni VK, Proteasome impairment by α-synuclein (2017)](https://pubmed.ncbi.nlm.nih.gov/28945746/)
[Zhang Y, Tu C, Zhang D, et al, Endo-lysosomal pathway and ubiquitin-proteasome system dysfunction in Alzheimer's disease pathogenesis (2019)](https://pubmed.ncbi.nlm.nih.gov/30890471/)
[Murata S, Yashiroda H, Tanaka K, Molecular mechanisms of proteasome assembly (2009)](https://pubmed.ncbi.nlm.nih.gov/19165213/)
[Gu Y, Wang X, Huang Y, et al, PAC1-PAC2 proteasome assembly chaperone retains the core α4-α7 assembly intermediates in the cytoplasm (2018)](https://pubmed.ncbi.nlm.nih.gov/30133132/)
[Kopp F, Dahlmann B, Kuehn L, Intermediates in the formation of mouse 20S proteasomes: implications for the assembly of precursor beta subunits (1997)](https://pubmed.ncbi.nlm.nih.gov/9311996/)
[Fricker LD, Gomez C, Hwang JR, et al, Early proteasome downregulation and dysfunction drive proteostasis failure in Alzheimer's disease (2025)](https://pubmed.ncbi.nlm.nih.gov/40488453/)
[Mazzetti S, Basellini MJ, Ferri V, et al, Early-onset impairment of the ubiquitin-proteasome system in dopaminergic neurons caused by α-synuclein (2020)](https://pubmed.ncbi.nlm.nih.gov/32059750/)
[Korolchuk VI, Menzies FM, Rubinsztein DC, The dialogue between the ubiquitin-proteasome system and autophagy: Implications in ageing (2020)](https://pubmed.ncbi.nlm.nih.gov/33130248/)